SEPTEMBER 25, 2023 — Paul Rad, a core faculty member in the UTSA School of Data Science, and Marc Feldman, M.D., a cardiologist at UT Health San Antonio, are teaming up to develop a cutting-edge medical technology driven by artificial intelligence that identifies the exact composition of coronary heart disease. Their innovation, a generative AI model based on existing optical arterial scans, would enable clinicians to view inside a person’s coronary artery in the heart catheterization laboratory to assess plaque build-up and future risk of heart attacks in real time.
Most people are familiar with medical imaging tools such as x-rays, ultrasounds and MRIs, but cardiologists need technology that is much more precise to see inside coronary arteries, which supply blood to the heart. This viewpoint is essential to predict future heart attacks. This condition is often caused by the buildup of fatty plaques that reduce arterial flow, or rupture and trigger blood clots that can block the artery entirely, halt blood flow to the heart and cause tissue damage.
“We know at death, by autopsy, the characteristics of plaque that lead to heart attacks. They are usually large amounts of lipid covered by very thin caps of fibrous tissue,” said Feldman, a professor emeritus at UT Health San Antonio.
While an autopsy allows for definitive analysis of an artery via histology, or microscopic analysis, clinicians cannot microscopically analyze an artery while a person is alive.
Instead, clinicians use optical coherence tomography (OCT), a procedure that is most commonly used for retinal scans.
Several years ago, Feldman and former UT Austin engineering professor Thomas Milner collaborated and adapted the OCT technology to peek inside the coronary arteries of living patients.
Coronary OCT works by capturing the reflection of an infrared light emitted by a catheter inserted into the artery in question. This allows doctors to “see” inside an artery and provides images with much higher resolution than other imaging techniques. However, this level of detail also makes the images inherently more difficult to analyze.
“The problem is that this optical technique gives so much information, it’s almost too much,” Feldman explained, “so the physicians that are using it are overwhelmed by the amount of information and detail.”
This diagram shows how detection software using AI can assist doctors in understanding the composition of coronary plaque. This kind of automated detection can relieve doctors from the burden of searching numerous heart scans for plaque. It can also increase the value and use of OCT systems in clinical use.
Paul RadThis is where artificial intelligence — and UTSA’s Rad — come into the picture. Rad and UTSA doctoral research assistant, Paul Young, are developing an algorithm that can interpret coronary OCT images faster and more reliably than humans.
“The goal is to build a generative AI model that can learn from the existing images Dr. Feldman has captured in his lab, so our model can predict heart attacks at the earliest stage and doctors can make impactful decisions to avoid potential heart damage in the future,” Rad said.
The images Rad will use are crucial to the project. Feldman and his team, including UT Health San Antonio senior research scientists Sasha Gruslova and Drew Nolen and research assistant Luis Diaz, have spent the last five years collecting approximately 2,000 OCT scans and histology images. Feldman believes it is the largest dataset of its kind in the world. They hope that by matching an OCT image to its corresponding histology, their AI model will begin learning to interpret those images. Rad says it’s not as easy as it sounds.
“The OCT sees a reflection of light in the material of the artery then Paul [Young] has to make sure the AI’s learning is adjusted based on the reflection of different materials because lipid is different from other materials in arteries,” he explained. “Basically, his model has to learn the physics of light.”
If the team’s model can learn the physics, the implications will be of important clinical value. An AI model that can accurately identify what cardiologists see in real time will allow them to make on-the-spot treatment decisions such as whether to place a biodegradable stent (future goal) a patient needs and which location is the safest for any given patient. Just as importantly, the AI would enable a uniformity and consistency of analysis that humans struggle to match.
Equally as important, if the model became sufficiently advanced, it could likewise be used to help humans better understand and interpret OCT imaging. From there, Feldman and Rad believe the possibilities for this technology are all but limitless.
“Once you provide new information to a bunch of smart doctors, they’ll start creating new ways to apply or use it that we can’t even foresee right now,” he said.
Rad added, “This has the potential to change health care as we know it.”
Feldman’s lab is funded by The Clayton Foundation for Research, a Houston-based nonprofit medical research organization. He and Rad are partnering with Gentuity, a manufacturer and supplier of medical equipment, to make their technology widely accessible when the project is completed, which Feldman anticipates will take several years.
